Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Spyre Therapeutics, Inc. vs Vaxcyte, Inc.: key figures
| Rank | #2017 | #1939 |
|---|---|---|
| Price | $109.00 | $67.53 |
| Market cap | $10.06B | $10.63B |
| Shares Outstanding | 92.29M | 157.39M |
| Change (1 day) | +4.95% | +5.70% |
| Change (1 year) | +381.66% | +48.25% |
The other way round: PCVX with the market cap of SYRE
If Vaxcyte, Inc. (PCVX) had the market cap of Spyre Therapeutics, Inc. (SYRE), one PCVX would cost $63.92, 5.35% less than today's price of $67.53.
Price of PCVX with the Market Cap of SYREPrice of SYRE with the Market Cap of PCVX: the last 12 months
The price of one SYRE if Spyre Therapeutics, Inc. had the market cap of Vaxcyte, Inc., at the end of each month. Highest: $115.16 (Nov 2026). Lowest: $20.72 (May 2026).
- $83.87 Dec 2025
- $97.38 Jan 2026
- $24.28 Feb 2026
- $22.85 Mar 2026
- $22.51 Apr 2026
- $20.72 May 2026
- $23.43 Jun 2026
- $90.42 Jul 2026
- $101.00 Aug 2026
- $94.61 Sep 2026
- $105.78 Oct 2026
- $115.16 Nov 2026
Questions about Spyre Therapeutics, Inc. and Vaxcyte, Inc.
What would the price of Spyre Therapeutics, Inc. be with the market cap of Vaxcyte, Inc.?
If Spyre Therapeutics, Inc. (SYRE) had the market cap of Vaxcyte, Inc. (PCVX), one SYRE would cost $115.16, 1.06 times today's price of $109.00.
How much bigger is Vaxcyte, Inc. than Spyre Therapeutics, Inc.?
The market cap of Vaxcyte, Inc. ($10.63B) is 1.06 times that of Spyre Therapeutics, Inc. ($10.06B). In Dec 2025 the gap was 2.56 times.
What would the price of Vaxcyte, Inc. be with the market cap of Spyre Therapeutics, Inc.?
If Vaxcyte, Inc. (PCVX) had the market cap of Spyre Therapeutics, Inc. (SYRE), one PCVX would cost $63.92, 5.35% less than today's price of $67.53.
How is this price calculated?
The market cap of Vaxcyte, Inc. ($10.63B) is divided by the number of SYRE in circulation (92.29M). Market cap is the price multiplied by the number of coins or shares in circulation.